{"casebody": {"status": "ok", "data": "<?xml version='1.0' encoding='utf-8'?><html><body><casebody firstpage=\"846\" lastpage=\"846\" xmlns=\"http://nrs.harvard.edu/urn-3:HLS.Libr.US_Case_Law.Schema.Case_Body:v1\">\n<parties id=\"p-1\">BRISTOL-MYERS SQUIBB COMPANY<br/> v.<br/> S.C. (ANDERSON)</parties>\n<docketnumber id=\"p-2\">S221038</docketnumber>\n<court id=\"p-3\">Supreme Court of California</court>\n<decisiondate id=\"p-4\">August 23, 2017</decisiondate>\n\n\n<judges id=\"p-7\">Votes: Cantil-Sakauye, C.J., Chin, Corrigan, Liu, Cu\u00e9llar and Kruger, JJ.</judges>\n<opinion type=\"majority\"><p id=\"p-5\">The above-entitled matter is transferred to the Court of Appeal, First Appellate District, Division Two for further proceedings consistent with Bristol-Myers Squibb Co. v. Superior Court (2017) --- U.S. ----, <extracted-citation case-ids=\"12604783\" index=\"0\" url=\"https://cite.case.law/s-ct/137/1773/\">137 S.Ct. 1773</extracted-citation>, <extracted-citation case-ids=\"12604783\" index=\"1\" url=\"https://cite.case.law/s-ct/137/1773/\">198 L.Ed.2d 395</extracted-citation>.</p><p id=\"p-6\">Werdegar, J., was absent and did not participate.</p></opinion>\n</casebody>\n</body></html>"}}